SCHEMBL27358538

SCHEMBL27358538

CC(C)c1cccc(N)c1C=N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 4/20 0.40
▸ GABRA1 P14867 3/20 0.40
▸ TSHR P16473 3/20 0.40
▸ GABRG2 P18507 2/20 0.40
▸ GABRB3 P28472 2/20 0.40
▸ GABRB2 P47870 2/20 0.40
▸ CA1 P00915 2/20 0.40
▸ CA2 P00918 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ FAAH O00519 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ GABRB1 P18505 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ SLC6A2 P23975 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ GABRA5 P31644 1/20 0.40
▸ GABRA3 P34903 1/20 0.40
▸ HTR2B P41595 1/20 0.40
▸ GABRA2 P47869 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5455457 0.85 GABRA1 (0.48) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL28941879 0.83 GABRA1 (0.46) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL10078188 0.78 CYP3A4 (0.43) CYP3A4TSHRCA1CA2HPGD
SCHEMBL19122282 0.78 GABRA1 (0.41) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL19779592 0.76 GABRA1 (0.40) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL19779677 0.76 CYP1A2 (0.42) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL19297114 0.75 — —
SCHEMBL20350334 0.74 GABRA1 (0.35) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL21780673 0.74 GABRA1 (0.35) CYP3A4GABRA1TSHRGABRG2GABRB3
SCHEMBL23097786 0.73 GABRA1 (0.42) CYP3A4GABRA1TSHRGABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040080-A1 KRAS INHIBITOR CONJUGATES ERASCA, INC. (US) 2024-02-22 — — WO disclosed
Send feedback